US5053050A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Compositions for repair of cartilage and bone
Assignee: Individual
•
Filing: 1988-04-29
•
Granted: 1991-10-01
•
Expires: 2008-04-29
Abstract
Abstract A defect is provided in cartilage or bone, or both, to excize damaged or pathological tissue, and it is filled with an implant having capability for complete regeneration of the skeletal tissue as a chondrogenic or osteogenic phenotype. The implant comprises cells expressing a chondrocyte phenotype (80×10 6 cells/ml) embedded in a biocompatible matrix having about 20% serum, which provides a permissive environment for maturation and transformation of the implant to a fully integrated state with the surrounding tissue. A portion of the implant may comprise a bone segment or a bone substitute.
Inventors
- 👤 Samuel Itay
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 02:31
CPC Classifications
A; A61; A61K; A61K35/00; A61K35/12; A61K35/34; A61F; A61F2/00; A61F2/02; A61F2/28; A61F2/30; A61F2/30756; A61K35/28; A61L; A61L24/00; A61L24/0005; A61L24/04; A61L24/10; A61L24/106; A61F2002/30001; A61F2002/30003; A61F2002/3006; A61F2002/30062; A61F2210/00; A61F2210/0004; Y; Y10; Y10S; Y10S623/00; Y10S623/915; Y10S623/919
Claims Analysis
Total Claims: 2
Claim 1
Independent Claim
96 words
A method of comparing a skeletal tissue implant comprising the step of: purification, proliferation and manipulation of a cell population expressing a specific chondrogenic or osteogenic phenotype, the proliferating cells being selected from the class consisting of bone marrow stroma cells, embryonal committed chondrocytes, and any undifferentiated mesenchymal cells and being concentrated to between 80 ×10 6 and 160 ×10 6 cells/ml; and embedding the cells in a biological resorbable immobilization vehicle (BRIV) comprising at least 15-14 30% serum, 100-150 mg/ml fibrinogen, and 60-90 units/ml thrombin, and wherein the BRIV further includes about 2,000 units/ml aprotonin.
Claim 2
Independent Claim
96 words
A method of comparing a skeletal tissue implant comprising the step of: purification, proliferation and manipulation of a cell population expressing a specific chondrogenic or osteogenic phenotype, the proliferating cells being selected from the class consisting of bone marrow stroma cells, embryonal committed chondrocytes, and any undifferentiated mesenchymal cells and being concentrated to between 80 ×10 6 and 160 ×10 6 cells/ml; and embedding the cells in a biological resorbable immobilization vehicle (BRIV) comprising at least 15-14 30% serum, 100-150 mg/ml fibrinogen, and 60-90 units/ml thrombin, and wherein the BRIV further includes about 2,000 units/ml aprotonin.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-09-30 | 1995-04-01 | 1995-10-01 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-09-30 | 1999-04-01 | 1999-10-01 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-09-30 | 2003-04-01 | 2003-10-01 | $7700.00 | Window Closed / Lapsed |